| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |